Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

Clinical trial NCT00032773 · TERMINATED

Trial details

NCT number: NCT00032773
Sponsor: Astex Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Graft Versus Host Disease

Start date: 2002-01-30
Primary completion: 2005-11-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.